Sustained Release Lidocaine for the Treatment of Postoperative Pain
Status:
Recruiting
Trial end date:
2023-05-27
Target enrollment:
Participant gender:
Summary
In this study, the investigators are testing a new formulation of lidocaine for its
suitability in managing postoperative pain after pelvic surgery. The new formulation ST-01 is
a sustained release lidocaine formulation and is expected to provide pain relief over
multiple days. Currently, the drug lidocaine is not available as an injectable slow-release
formulation.